Norwegian (OSEAX) Biotech Industry Analysis
UpdatedMay 08, 2024
DataAggregated Company Financials
Companies11
- 7D2.8%
- 3M-42.3%
- 1Y-65.2%
- YTD-47.0%
The Biotech industry is up 3.3% in the last week, with Nykode Therapeutics up 5.6%. During this same period, the Nordic Nanovector underperformed, falling 18%. In the past year, the industry is down 66%. In the next few years, earnings are forecast to decline by 10% annually.
Industry Valuation and Performance
Has the Norwegian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 08 May 2024 | kr8.7b | kr658.8m | -kr958,382,602.58 | 35.3x | -9.1x | 13.3x |
| Fri, 05 Apr 2024 | kr9.0b | kr657.0m | -kr940,318,813.66 | 39.1x | -9.6x | 13.7x |
| Sun, 03 Mar 2024 | kr14.5b | kr659.5m | -kr921,184,513.76 | 42.2x | -15.8x | 22x |
| Tue, 30 Jan 2024 | kr16.5b | kr656.1m | -kr1,358,036,154.00 | 59.7x | -12.2x | 25.2x |
| Thu, 28 Dec 2023 | kr16.2b | kr650.9m | -kr1,343,120,866.00 | 60.9x | -12.1x | 24.9x |
| Sat, 25 Nov 2023 | kr15.6b | kr660.0m | -kr1,369,442,606.00 | 59.5x | -11.4x | 23.6x |
| Mon, 23 Oct 2023 | kr15.8b | kr489.8m | -kr1,553,720,835.00 | 97.6x | -10.2x | 32.3x |
| Wed, 20 Sep 2023 | kr15.5b | kr625.1m | -kr1,461,471,751.00 | 54.6x | -10.6x | 24.8x |
| Fri, 18 Aug 2023 | kr16.0b | kr559.8m | -kr1,471,026,717.00 | 53.2x | -10.9x | 28.5x |
| Sun, 16 Jul 2023 | kr15.6b | kr553.9m | -kr1,447,285,150.00 | 58.1x | -10.8x | 28.3x |
| Tue, 13 Jun 2023 | kr16.4b | kr562.5m | -kr1,491,283,114.00 | 67.9x | -11x | 29.1x |
| Thu, 11 May 2023 | kr16.7b | kr540.0m | -kr1,437,699,710.00 | 29.8x | -11.6x | 31x |
| Sat, 08 Apr 2023 | kr16.0b | kr549.5m | -kr1,548,563,376.00 | 32.1x | -10.3x | 29.1x |
| Mon, 06 Mar 2023 | kr17.4b | kr535.6m | -kr1,675,530,818.00 | 30.5x | -10.4x | 32.4x |
| Wed, 01 Feb 2023 | kr18.0b | kr812.7m | -kr1,396,218,423.00 | 24.6x | -12.9x | 22.2x |
| Fri, 30 Dec 2022 | kr19.0b | kr807.9m | -kr1,393,710,457.00 | 39.6x | -13.7x | 23.6x |
| Sun, 27 Nov 2022 | kr17.5b | kr808.2m | -kr1,393,842,903.00 | 36.2x | -12.5x | 21.6x |
| Tue, 25 Oct 2022 | kr16.9b | kr813.1m | -kr1,364,539,057.00 | 36.6x | -12.4x | 20.8x |
| Thu, 22 Sep 2022 | kr16.9b | kr803.0m | -kr1,370,513,175.00 | 35.9x | -12.3x | 21x |
| Sat, 20 Aug 2022 | kr22.2b | kr775.2m | -kr1,379,950,009.00 | 39x | -16.1x | 28.6x |
| Mon, 18 Jul 2022 | kr19.1b | kr779.8m | -kr1,383,776,932.00 | 41.8x | -13.8x | 24.5x |
| Wed, 15 Jun 2022 | kr20.2b | kr1.1b | -kr1,036,585,610.00 | 41.3x | -19.5x | 18.3x |
| Fri, 13 May 2022 | kr21.4b | kr1.1b | -kr1,001,244,726.00 | 37.7x | -21.4x | 19.6x |
| Sun, 10 Apr 2022 | kr25.4b | kr1.1b | -kr984,966,648.00 | 43.3x | -25.8x | 24.1x |
| Tue, 08 Mar 2022 | kr22.4b | kr2.7b | kr434.9m | 7.8x | 51.5x | 8.2x |
| Thu, 03 Feb 2022 | kr32.9b | kr2.7b | kr453.3m | 13.3x | 72.6x | 12.3x |
| Sat, 01 Jan 2022 | kr40.9b | kr2.2b | kr46.3m | 43.9x | 883.1x | 18.7x |
| Mon, 29 Nov 2021 | kr40.1b | kr2.2b | kr91.4m | 42.1x | 438.5x | 18x |
| Wed, 27 Oct 2021 | kr35.9b | kr2.5b | kr445.6m | 14.7x | 80.5x | 14.2x |
| Fri, 24 Sep 2021 | kr38.9b | kr2.6b | kr478.0m | 16.2x | 81.3x | 15.1x |
| Sun, 22 Aug 2021 | kr38.3b | kr2.6b | kr508.1m | 16.9x | 75.4x | 14.9x |
| Fri, 09 Jul 2021 | kr39.8b | kr2.6b | kr508.1m | 17.1x | 78.4x | 15.5x |
Price to Earnings Ratio
77.6x
Current Industry PE
- Investors are pessimistic on the Norwegian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 21.4x is higher than the industry's current PS ratio of 13.3x.
Past Earnings Growth
- Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 36% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Norwegian Healthcare industry?
| NO Market | 1.41% | |
| Healthcare | -0.45% | |
| Biotech | 2.78% | |
| Biotech | 2.78% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NYKD Nykode Therapeutics | kr14.06 | 5.2% +kr225.3m | -44.0% | PS31.6x | |
| HBC Hofseth BioCare | kr2.15 | 5.9% +kr47.4m | -32.6% | PS3.9x | |
| ABS Arctic Bioscience | kr10.40 | 6.1% +kr15.2m | -5.5% | PS7.8x | |
| ULTI Ultimovacs | kr7.29 | 4.4% +kr10.7m | -94.2% | PB0.9x | |
| PCIB PCI Biotech Holding | kr1.65 | 3.8% +kr2.2m | -22.4% | PS20.5x |